Professional Experience
Assistant Professor of Clinical Nursing, University of Rochester (Research), Rochester, NY, US. 2016 - Current

Nurse Scientist, Wilmot Cancer Institute, University of Rochester (Research), Rochester, NY, US. 2016 - Current

Nurse Practitioner, Wilmot Cancer Institute, University of Rochester (Blood and Marrow Transplantation), Rochester, NY, US. 1998 - Current

Presentations
Some Simple Ways to Turn Your Clinical Question into a Workable Project
Kelly Clark BS, RN
WCI Nursing Research Conference, Wilmot Cancer Institute, 2021
Rochester, New York

Some Simple Ways to Turn Your Clinical Question into a Workable Project
Kelly Clark BS, RN
WCI Nursing Research Conference (enduring Oct 2021 to Jan 2022, via MyPath), Wilmot Cancer Institute, 2021
Rochester, New York

Heritable Hematologic Malignancies
none
NUR 438, University of Rochester, 2021
Rochester, New York

Cancer in Primary Care
none
NUR 445, University of Rochester, 2021
Rochester, New York

Managing the Care of the Research Participant Workshop Co-coordinator December 2019
Kelly Clark BS, RN & Jamie Littleton MS, RN
Oncology Nursing Research Committee Workshop Series, Wilmot Cancer Institute, 2019
Rochester, New York

Publications
Andolina, J. R., Walia, R., Oliva, J., Baran, J., Liesveld, J., Becker, M. W., Busacco, A., & Coppage, M. (2020). Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.. Human Immunology, 81 (8), 407-412. DOI: https://doi.org/10.1016/j.humimm.2020.05.006

Hashmi, S., Oliva J. L.*, Liesveld, J. L., Phillips, G. L. 2nd, Milner, L., Becker, M. W. (*Contributions. SH and JLO contributed equally to all sections of the manuscript) (2013). The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation. Leukemia Research, 37 (9), 1052-6. DOI: doi: 10.1016/j.leukres.2013.06.013

Keller, S. F., Kelly, J. L,, Sensenig, E., Andreozzi, J., Oliva, J., Rich, L., Constine, L., Becker. M., Phillips, G., Liesveld, J., Fisher, R. I., Bernstein, S.H., Friedberg, J. W. (2011). Late Relapses Following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin Lymphoma (HL) in the ABVD Therapeutic Era. Biology of Blood and Marrow Transplantation, 18 (4), 640-627. DOI: doi: 10.1016/j.bbmt.2011.08.012